Key Takeaways
- Double-digit growth across both segments: Personal Care grew 22.5% and Food & Nutrition grew 15.4% in Q4, with comparable base business delivering low double-digit growth backed by mid- to high-single digit volume gains.
- Margin intent, not a fixed promise: Management reiterated a clear intent to move EBITDA margins to 17%–18% over the next 2–3 years, but explicitly declined to call it guidance, citing commodity volatility as the reason it will not tie itself to a number.
- Rite Bite integration on track, accretion promised: The Naturell India acquisition is expected to become cash EPS accretive by FY '26, with margins currently in low single digits and operating leverage still to come.
- Everyuth and Nycil are widening their leads: Everyuth Scrub gained 321 bps of market share to 48.5% in a category growing 20%; Nycil holds 33.8% share in a prickly heat powder category growing 21%.
- What to watch next quarter: Whether the 17%–18% margin intent survives edible oil and milk inflation, the pace of Rite Bite margin build, and any stabilization in the nutritional drink category that declined 2.1% at MAT.
Segment & Brand Performance
- Personal Care momentum: The segment grew 22.5% in Q4 and 33.4% for the full year, driven by Everyuth's category leadership and new launches including a sheet mask range with three variants.
- Everyuth market position: The brand moved from #7 to #5 in overall facial cleansing; core scrub and peel-off categories grew 20% and 24% respectively at MAT, with Everyuth holding dominant shares in both.
- Nycil seasonality: The prickly heat powder category is heavily skewed, with only 10%–15% of sales occurring in Q2 and Q3 combined; management did not confirm an analyst's suggestion that 20%–25% of demand is non-seasonal.
- Glucon D stability: Maintained 58.8% market share in a glucose powder category growing 19.7% at MAT; the Glucon D Activors extension is meeting internal milestones though remains small.
- Nutritional drink softness: The category declined 2.1% at MAT with continued softness across key metrics; Complan holds 4.0% market share and performs well in quick commerce channels.
- Sugar Free dominance: Holds 95.9% share in sugar substitutes (category grew 6.7%); Sugar Free Green delivering strong double-digit growth; Sugar Free Gold Plus repositioned from aspartame to sucralose plus chromium after WHO's 2023 carcinogen classification.
- Nutralite trajectory: Delivering double-digit growth with a 5-year CAGR supported by consistent volume growth, driven by dedicated B2B and B2C teams.
- I'm Lite recovery: The sweetener brand, launched after trademark issues with the earlier Sugarlite brand, is recovering but still behind in a couple of markets and channels; management expects it to eventually reach at least 15%–20% of the overall sweeteners portfolio.
Tarun Arora: "We want to be a stronger, larger science-based, high-performing product business with credible evidence of performance in 2 spaces."
Margin Trajectory & Cost Management
- Gross margin stability: Modest upward trend YoY despite inflationary challenges, achieved through strategic hedging, favorable product mix, and calibrated pricing; consistent margin expansion to net sales across all quarters YoY.
- Employee cost pressure: Higher variable pay from good performance and the addition of acquired entity teams drove the increase; field force employee costs sit in other expenses, not the employee cost line.
- Depreciation increase: Amortization of acquired brands from NIPL, Rite Bite and Max Protein over 15 years is lifting depreciation.
- Gross margin headroom: Management sees scope for another couple of percentage points of improvement over the next couple of years from product mix, pricing power (with lag), and cost management; past challenges in FY '21–'23 were attributed to a global commodity cycle that disproportionately impacted pricing ability.
- A&P efficiency: The company wants to operate closer to 13% of sales (+/-0.5%), with room for another 0.5%–1% improvement, though the pace will depend on the year's initiatives and growth opportunities.
- Tax shield: No cash tax payout is expected in FY '26 and FY '27, with only deferred tax liability to be recognized.
Tarun Arora: "I can't tie myself and say this is exactly what it is, and I'll change my guidance every time I face pressure. This is the intent, and our action is going to be guided by this intent."
Acquisitions & Capital Allocation
- Rite Bite (Naturell India): Acquired at near-breakeven; integration and digitalization transformation progressing smoothly; business continuing to deliver strong growth; margins currently positive in low single digits with operating leverage and synergy benefits expected to build from here.
- Rite Bite growth ambition: Management hopes to continue the historical 25%+ CAGR and is tracking reasonably well on that trajectory; the brand has seen higher than 50% growth in the past, supported by tailwinds and execution.
- Acquisition philosophy: Management will not seek acquisitions for scale, citing the Kraft Heinz India experience as a key lesson; the strategy is bolt-on spaces adjacent to existing categories where the company would have liked to participate organically.
- Size preference: Typical targets are in the ₹100–₹200 crore revenue range, large enough to have a proof point of performance and headroom for growth; very small deals (₹25–₹50 crore) will be exceptions.
- Funding approach: Acquisitions will be funded from internal accruals; management sees nothing disproportionate on the current horizon that would require external funding.
- Valuation discipline: When pressed on IRR or payback criteria, management gave a general answer about following a detailed discounting method without providing specific thresholds; it also declined to engage with an analyst's characterization of a prior acquisition as a "disaster" with less than 3% yield, calling the assessment inaccurate.
Tarun Arora: "We are not seeking acquisition for scale. That's one of the key tasks we did when we did with Kraft Heinz India acquisition."
Channel & Demand Dynamics
- Rural-urban divergence: Rural markets continue to outperform urban areas, buoyed by stronger consumer sentiment; easing food inflation is contributing to a decline in overall inflation, though edible oil and dextrose monohydrate prices remain volatile.
- Quick commerce effect: The channel increases accessibility in the top 10–15 urban towns, helping democratize reach and attract new consumers; Complan and cold chain products like butter perform particularly well; the channel replaces some existing space but also expands the consumer base.
- Digital commerce expansion: Marketplaces are deepening reach into smaller towns while quick commerce accelerates instant small-basket purchases in metros.
- Channel inventory management: Glucon D and Nycil operate on a replenishment-based system; distributors carry fairly high inventory from January through March (supported by the company), which drops toward May–June; challenges are corrected quickly.
Tarun Arora: "it obviously helps democratize better, and therefore, be able to reach some new consumers"
New Initiatives & Portfolio Expansion
- Everyuth sheet masks: Three variants launched (Golden Glow, anti-pollution, Aloe Cucumber), marking the brand's entry into the sheet mask category.
- Sugarfree D'lite cookies: Extended through organized channels domestically with favorable consumer feedback; a dedicated site is being built to capture both domestic and international portfolios on sugar-free extensions.
- VieMax (adult nutrition): Response has been fairly good though the market is sluggish; the company is taking an expert marketing route with doctor detailing and digital; management views this as a long-haul effort and hopes to eventually build adult nutrition presence to at least match children's nutrition presence.
- International ambition: Management believes the international business can double every three years, eventually reaching 8%–10% of the portfolio.
- Revenue milestone: The company wants to cross ₹5,000 crores in revenue, whether that takes three years or five.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin intent | Move to 17%–18% | Next 2–3 years |
| Gross margin improvement | Another couple of percentage points | Next couple of years |
| Rite Bite cash EPS accretion | Cash EPS accretive | FY '26 |
| Rite Bite growth | Continue 25%+ CAGR | Ongoing (tracking reasonably well) |
| A&P to sales | Operate closer to 13% (+/-0.5%) | No fixed date |
| I'm Lite portfolio share | At least 15%–20% of sweeteners portfolio | Eventually |
| International business | Double every 3 years, reach 8%–10% of portfolio | No fixed date |
| Revenue milestone | Cross ₹5,000 crores | 3–5 years |
| Cash tax | No cash tax payout | FY '26 and FY '27 |
| Acquisition strategy | Bolt-on only, ₹100–₹200 crore range, funded from internal accruals | Ongoing |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated net sales | ₹910.6 cr, +17% YoY |
| Volume growth | 13% YoY |
| FY25 revenue from operations | ₹2,691.2 cr, +16.2% YoY with 12.4% volume growth |
| Revenue CAGR from FY21 base | ~10% |
| Personal Care segment growth | 22.5% YoY for Q4; 33.4% for FY25 |
| Food & Nutrition segment growth | 15.4% YoY for Q4; 13% for FY25 |
| Gross margin expansion | 42 bps YoY in Q4; 168 bps for FY25; 361 bps over FY24 and FY25 combined |
| EBITDA | ₹190 cr, +17.1% YoY |
| Net profit after tax | ₹171.9 cr, +14.4% YoY |
| FY25 EBITDA | ₹379.7 cr, +23.2% YoY |
| FY25 net profit (excl. exceptional item and one-time deferred tax assets) | ₹341 cr, +30% YoY |
| EPS (FY25) | ₹54.52, up from ₹41.94 in FY24 |
| Final dividend recommended | ₹6 per share (60% of face value ₹10), 20% increase over previous year |
| Stock split | 1:5, face value reducing from ₹10 to ₹2 |
| Cash conversion from operations | 380 crore, 100% realization of EBITDA |
| Organized trade saliency (FY25) | 23% of sales; e-commerce 10%, non-trade 13% |
| Quick commerce share of e-commerce | 41% |
| Everyuth Scrub market share | 48.5%, +321.4 bps YoY (MAT March 2025) |
| Everyuth Peel-off market share | 77.7%, +6.1 bps YoY (MAT March 2025) |
| Everyuth overall facial cleansing market share | 7.7%, 5th position (MAT March 2025) |
| Nycil market share (prickly heat powder) | 33.8%, #1 position (MAT March 2025) |
| Glucon D market share (glucose powder) | 58.8% (MAT March 2025) |
| Sugar Free market share (sugar substitute) | 95.9% (MAT March 2025) |
| Rite Bite growth since acquisition | Higher than 50% over 4 months; margins positive, low single digits |
| Rite Bite historical CAGR | 25%+ over last 3 to 5 years |
| A&P to sales ratio target | ~13% (+/-0.5%), with room for 0.5% to 1% improvement |
| EBITDA margin target | 17% to 18% over next couple of years |
| Revenue aspiration | ₹5,000 cr benchmark, in 3 to 5 years |
| Cash tax payout | Nil for FY26 and FY27; only deferred tax liability |